Evidence map›Paper›PMID 41606651›Full record

ReviewTranslational neurodegeneration2026

Proximity labeling in neuroscience: decoding molecular landscapes for precision neurology.

Xia Gao, Jianjun Lu, Peipei Chen, Xinna Wang, Longlong Zheng, Yuyin Shao, Huali Shen, Qian Yang

Abstract readReview
In one paragraph

Review in Translational neurodegeneration, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xia GaoDepartment of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China.
Jianjun LuDepartment of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China.
Peipei ChenInstitutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Xinna WangDepartment of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China.
Longlong ZhengDepartment of Interventional Radiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China.
Yuyin ShaoLeibniz-Forschungsinstitut für Molekulare Pharmakologie, 13125, Berlin, Germany.
Huali ShenInstitutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China. shenhuali@fudan.edu.cn.
Qian YangDepartment of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, China. qianyang@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-2166-6499

Funding

General Medical Research Program 24YXYJ0124Innovative Research Group Project of the National Natural Science Foundation of China 82221001-4Key Research and Development Projects of Shaanxi Province 2023-ZDLSF-52Natural Science Basic Research Program of Shaanxi Province 2025JC-YBQN-1036Phoenix Talent Initiation Program 2023YFJH006Tangdu Hospital's "Pioneer" Research Initiative Grant 2022TDGS006
6 · The paper itself

Abstract

The intricate cellular architecture and dynamic molecular interplay in the nervous system have long challenged mechanistic studies of neurological diseases. Conventional approaches often miss the transient, low-affinity, or spatially confined interactions that underlie neural homeostasis and pathogenesis. Proximity labeling (PL) technologies overcome this limitation by enabling in situ capture of these elusive molecular events within living systems. Through spatially restricted biotinylation, PL methods, including engineered biotin ligases (e.g., TurboID), peroxidases (e.g., APEX2), and emerging photocatalytic platforms, allow high-resolution mapping of proteomes and interactomes within defined subcellular compartments, cell types, and cell-cell interfaces. In this review, we systematically outline the principles of PL and its transformative applications in constructing molecular atlases of the nervous system. We highlight how these tools are revolutionizing our understanding of brain function by elucidating pathophysiological mechanisms in Alzheimer's disease, Parkinson's disease and other neurological disorders. Furthermore, we discuss how PL accelerates the translation of basic research into clinical practice by facilitating the discovery of mechanistic biomarkers and druggable targets. Finally, we address current challenges and future directions, including integration with multi-omics and single-cell methodologies, and conclude that PL can advance precision neurology by bridging molecular neurobiology with therapeutic innovation.

Indexed as

Nervous System DiseasesNeurologyNeurosciencesPrecision MedicineStaining and LabelingAnimalsHumansProteomicsBiomarker discoveryNeurological disordersProtein-protein interactionProximity labelingSpatial proteomicsTherapeutic targets

Identifiers

PMID41606651
PMCPMC12853706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.